Cytotherapy: Impact Factor, Indexing, Publication Time & Fees


The Cytotherapy is reputed journal publishes research related to Genetics (clinical) (Q1); Oncology (Q1); Transplantation (Q1); Cancer Research (Q2); Cell Biology (Q2); Immunology (Q2); Immunology and Allergy (Q2). The ISSN of the journal is .

Through this web page, researchers can check the indexing, publication fee, journal quartile, and journal aim & scope.

Cytotherapy: Details

Journal TitleCytotherapy
PublisherElsevier B.V.
Publication CountryUnited States
ISSN14772566, 14653249
Publication AreaBiochemistry, Genetics and Molecular Biology; Immunology and Microbiology; Medicine
Publication LanguageENG
Review Process
Scopus IndexedYes

Cytotherapy Impact Factor

The Impact Factor of Cytotherapy in 2026 is 4.5.

Journal Quartile

The Cytotherapy is ranked in Q2.

Indexing

The Cytotherapy is indexed in: Web of Science.



Similiar journals to publish


Cytotherapy
ISSN:
Publisher: Elsevier B.V.
Journal Scope: Genetics (clinical) (Q1); Oncology (Q1); Transplantation (Q1); Cancer Research (Q2); Cell Biology (Q2); Immunology (Q2); Immunology and Allergy (Q2)